{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:43:34Z","timestamp":1785242614306,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jtha.2023.10.023","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T04:51:57Z","timestamp":1699073517000},"page":"534-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies"],"prefix":"10.1016","volume":"22","author":[{"given":"Ilenia","family":"Calcaterra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Tufano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Strano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rufolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Donnarumma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzina","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"De Ruberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Guerrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Conca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Iannuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Di Minno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.10.023_bib1","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/bloodadvances.2022007397","article-title":"Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study","volume":"6","author":"Ageno","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.10.023_bib2","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/jth.14836","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation","volume":"18","author":"Di Nisio","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.023_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2018.02.143","article-title":"RIETE Investigators. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis","volume":"164","author":"Tufano","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.10.023_bib4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cgh.2009.09.019","article-title":"Survival and recurrence in patients with splanchnic vein thromboses","volume":"8","author":"Thatipelli","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jtha.2023.10.023_bib5","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamainternmed.2015.3184","article-title":"Long-term clinical outcomes of splanchnic vein thrombosis: results of an international registry","volume":"175","author":"Ageno","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtha.2023.10.023_bib6","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1055\/s-0035-1550439","article-title":"Splanchnic vein thrombosis","volume":"41","author":"Valla","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.10.023_bib7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11239-015-1171-0","article-title":"Managing unusual presentations of venous thromboembolism","volume":"39","author":"Ageno","year":"2015","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2023.10.023_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11239-015-1308-1","article-title":"Guidance for the management of venous thrombosis in unusual sites","volume":"41","author":"Ageno","year":"2016","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2023.10.023_bib9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1055\/s-0040-1722607","article-title":"Cancer-associated splanchnic vein thrombosis","volume":"47","author":"Cohen","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.10.023_bib10","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2023.10.023_bib11","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1182\/bloodadvances.2022007961","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis","volume":"6","author":"Candeloro","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.10.023_bib12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"key":"10.1016\/j.jtha.2023.10.023_bib13","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2023.10.023_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/bmjebm-2022-112102","article-title":"Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane","volume":"28","author":"Flemyng","year":"2023","journal-title":"BMJ Evid Based Med"},{"key":"10.1016\/j.jtha.2023.10.023_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2023.10.023_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","article-title":"Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis","volume":"323","author":"Sterne","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2023.10.023_bib17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.jtha.2023.10.023_bib18","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/liv.13285","article-title":"Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis","volume":"37","author":"De Gottardi","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jtha.2023.10.023_bib19","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/MEG.0000000000001846","article-title":"Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis","volume":"32","author":"Ai","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jtha.2023.10.023_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.vph.2018.05.002","article-title":"Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis","volume":"113","author":"Hanafy","year":"2019","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.jtha.2023.10.023_bib21","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/MEG.0000000000001958","article-title":"Evaluation of the efficacy and safety of direct oral anticoagulants in the treatment of portal vein thrombosis","volume":"33","author":"Ilcewicz","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jtha.2023.10.023_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.thromres.2021.03.018","article-title":"Splanchnic vein thrombosis: clinical manifestations, risk factors, management, and outcomes","volume":"202","author":"Kawata","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.10.023_bib23","first-page":"209","article-title":"Risk factors, clinical presentation, diagnosis, and treatment outcomes of portal vein thrombosis: a five-year hospital-based study from Qatar","volume":"14","author":"Khan","year":"2022","journal-title":"J\u00a0Clin Med Res"},{"key":"10.1016\/j.jtha.2023.10.023_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/hepr.12895","article-title":"Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis","volume":"48","author":"Nagaoki","year":"2018","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jtha.2023.10.023_bib25","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1007\/s10620-020-06695-4","article-title":"Safety, efficacy, and long-term outcomes of anticoagulation in cirrhotic portal vein thrombosis","volume":"66","author":"Naymagon","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jtha.2023.10.023_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ibd\/izaa053","article-title":"The natural history, treatments, and outcomes of portal vein thrombosis in patients with inflammatory bowel disease","volume":"27","author":"Naymagon","year":"2021","journal-title":"Inflam Bowel Dis"},{"key":"10.1016\/j.jtha.2023.10.023_bib27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1182\/bloodadvances.2019001310","article-title":"The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis","volume":"4","author":"Naymagon","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.10.023_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/0268355518779517","article-title":"Evaluation of direct oral anticoagulants and vitamin K antagonists in mesenteric venous thrombosis","volume":"34","author":"Salim","year":"2019","journal-title":"Phlebology"},{"key":"10.1016\/j.jtha.2023.10.023_bib29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00508-018-1351-y","article-title":"Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function","volume":"130","author":"Scheiner","year":"2018","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.jtha.2023.10.023_bib30","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.cgh.2022.04.024","article-title":"Outcome of Budd-Chiari syndrome patients treated with direct oral anticoagulants: an Austrian multicenter study","volume":"21","author":"Semmler","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jtha.2023.10.023_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13356","article-title":"Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis","volume":"51","author":"Serrao","year":"2021","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.jtha.2023.10.023_bib32","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/jgh.14843","article-title":"Dabigatran as an oral anticoagulant in patients with Budd-Chiari syndrome post-percutaneous endovascular intervention","volume":"35","author":"Sharma","year":"2020","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jtha.2023.10.023_bib33","article-title":"How to treat patients with splanchnic vein thrombosis: recent advances","volume":"133","author":"Valeriani","year":"2023","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.jtha.2023.10.023_bib34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1055\/s-0040-1722192","article-title":"Anticoagulant treatment for splanchnic vein thrombosis in liver cirrhosis: a systematic review and meta-analysis","volume":"121","author":"Valeriani","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.023_bib35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41424-018-0043-2","article-title":"IRSVT study investigators. Long-term outcome of splanchnic vein thrombosis in cirrhosis","volume":"9","author":"Senzolo","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jtha.2023.10.023_bib36","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/S2352-3026(16)30020-5","article-title":"International Registry on Splanchnic Vein Thrombosis (IRSVT) study group. Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry","volume":"3","author":"Riva","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2023.10.023_bib37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/VHRM.S197732","article-title":"Splanchnic vein thrombosis: current perspectives","volume":"15","author":"Valeriani","year":"2019","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jtha.2023.10.023_bib38","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s10620-015-4012-2","article-title":"Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation","volume":"61","author":"Intagliata","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jtha.2023.10.023_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2016.02.024","article-title":"Survival after splanchnic vein thrombosis: a 20-year nationwide cohort study","volume":"141","author":"S\u00f8gaard","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.10.023_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221104797","article-title":"The efficacy and safety of anticoagulants in the treatment of cirrhotic portal vein thrombosis: a systematic review and meta-analysis","volume":"28","author":"Zhang","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.10.023_bib41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2019.03.070","article-title":"AGA clinical practice update: coagulation in cirrhosis","volume":"157","author":"O\u2019Leary","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtha.2023.10.023_bib42","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11739-015-1249-x","article-title":"Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature","volume":"10","author":"Dentali","year":"2015","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jtha.2023.10.023_bib43","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01097-2017","article-title":"Direct oral anticoagulants for the treatment of acute venous thromboembolism in patients with cancer: a meta-analysis of randomised controlled trials","volume":"50","author":"Di Minno","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtha.2023.10.023_bib44","first-page":"99","article-title":"IRSVT study group. Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry","volume":"40","author":"Ageno","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.10.023_bib45","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"ESC Scientific Document Group. The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2023.10.023_bib46","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII Faculty. Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jtha.2023.10.023_bib47","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623007936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623007936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:42:49Z","timestamp":1761536569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623007936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1538783623007936"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.10.023","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}